Devices › Wire, guide, catheter
Device brand name · Guide wire
Hi-Torque Balance Middleweight Universal Guide Wire: medical device reports filed with FDA
479 reports name it, 2002–2024. Manufacturer given most often on reports: Av-Temecula-Ct. Product code DQX.
- 479
- device reports naming the brand
- 0% of all MAUDE reports · about 20 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 51.1%
- classified as malfunction
- 57.4% across the product code
- 1.3%
- classified as death, as reported
- 6 reports · not verified by FDA
FDA's MAUDE database holds 479 reports that name the brand "Hi-Torque Balance Middleweight Universal Guide Wire" (guide wire), received between May 2002 and March 2024; the manufacturer given most often on reports is Av-Temecula-Ct. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (51.1%), injury (47.4%) and death (1.3%); across all wire, guide, catheter reports (product code DQX) death is recorded in 2.8% and malfunction in 57.4%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are difficult to remove (34.9%), source, detachment from (25.9%) and detachment of device component (21.5%). The patient problems coded most often are foreign body, removal of, therapy/non-surgical treatment, additional and foreign body in patient. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 33,838 reports carrying product code DQX. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Difficult to removethe device was hard to remove | 167 | 34.9% | 15.4% |
| Source, detachment from | 124 | 25.9% | 2.4% |
| Detachment of device component | 103 | 21.5% | 9.3% |
| Material separation | 90 | 18.8% | 10.4% |
| Stretched | 58 | 12.1% | 3.8% |
| Difficult to position | 43 | 9% | 2.6% |
| Improper or incorrect procedure or method | 37 | 7.7% | 2.3% |
| Breakthe device broke | 35 | 7.3% | 11.4% |
| Failure to advance | 35 | 7.3% | 4.8% |
| Entrapment of device | 30 | 6.3% | 5% |
| Physical resistance | 29 | 6.1% | 1.7% |
| Tip breakage | 23 | 4.8% | 3.8% |
| Sticking | 22 | 4.6% | 1.9% |
| Device damaged by another device | 15 | 3.1% | 0.8% |
| Device, removal of (non-implant) | 13 | 2.7% | 1.4% |
| Device, or device fragments remain in patient | 11 | 2.3% | 3.6% |
| Difficult to advance | 11 | 2.3% | 4.6% |
| Peeled/delaminated | 11 | 2.3% | 7.1% |
| Replace | 11 | 2.3% | 2.2% |
| Kinkedthe tube or line kinked | 7 | 1.5% | 1.8% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Foreign body, removal of | 49 | 10.2% |
| Therapy/non-surgical treatment, additional | 44 | 9.2% |
| Foreign body in patientpart of a device left in the patient | 38 | 7.9% |
| Nonresorbable materials, unretrieved in body | 33 | 6.9% |
| Vessel or plaque, device embedded in | 24 | 5% |
| No patient involvement | 21 | 4.4% |
| Surgical procedure | 17 | 3.5% |
| Perforation | 15 | 3.1% |
| Hospitalization required | 14 | 2.9% |
| Intimal dissection | 8 | 1.7% |
| Occlusion | 7 | 1.5% |
| Deaththe patient died; cause not stated by this term | 5 | 1% |
| Myocardial infarctionheart attack | 5 | 1% |
| Angina | 4 | 0.8% |
| Cardiac arrestthe heart stopped | 4 | 0.8% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Hi-Torque Balance Middleweight Universal Guide Wire | Product code DQX | All MAUDE reports |
|---|---|---|---|
| Reports | 479 | 33,838 | 26,136,888 |
| Share of that pool | — | 1.4% | 0% |
| Classified as death, per 1,000 reports | 13 | 28 | 9 |
| Classified as injury | 47.4% | 38.9% | 36.2% |
| Classified as malfunction | 51.1% | 57.4% | 62.3% |
| Filed by the manufacturer | 98.7% | 88.6% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code DQX
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| V-18 Control Wire | 554 | 47 | 0.7% |
| Amplatz Super Stiff | 658 | 50 | 4.7% |
| Starter guidewire | 422 | 179 | 1.2% |
| Amplatz Super Stiff Guidewire | 403 | 0 | 3% |
| Acs Hi-Torque Balance Middleweight Guide Wire | 380 | 0 | 3.2% |
| Arrow Ra Cath Set 22 Ga X 1-3/8 | 346 | 0 | 0% |
| Radifocus Glidewire | 330 | 25 | 2.1% |
| V-14 Controlwire | 325 | 0 | 0.3% |
| Pt | 322 | 13 | 4% |
| V-14? Control Wire? | 305 | 25 | 0.3% |
| Acs Hi-Torque Balance Middleweight Guide Wire With Hydrocoat Hydrophilic Coating | 304 | 0 | 1.3% |
| Guide Wires | 374 | 0 | 1.6% |
| Runthrough Ns | 259 | 0 | 1.9% |
| Hi-Torque Pilot Guide Wire | 256 | 0 | 4.3% |
| Hi-Torque Command 18 Guide Wire | 245 | 0 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Hi-Torque Balance Middleweight Universal Guide Wire reports
How many FDA reports name Hi-Torque Balance Middleweight Universal Guide Wire?
479 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (51.1%), injury (47.4%) and death (1.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
difficult to remove (34.9%), source, detachment from (25.9%), detachment of device component (21.5%), material separation (18.8%) and stretched (12.1%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (98.7%) and voluntary reports (0.4%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Hi-Torque Balance Middleweight Universal Guide Wire was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.